PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

Search

Reset

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : N

Records returned : 71 (on 21 Nov 2024 at 16:32:14).

Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
04.06.00
Nabilone
Nausea and vomiting (chemotherapy induced)
Non Formulary
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
CD
10.01.01
Nabumetone
Pain & inflammation - musculoskeletal
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Nadolol
No Information Returned
Nadolol with diuretic
No Information Returned
06.07.02
Nafarelin acetate
Transgender Health - Children & Young People
Amber
Formulations :
  • Nasal spray
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
06.07.02
Nafarelin acetate
Transgender Health - adults
Amber
Formulations :
  • Nasal spray
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
02.06.04
Naftidrofuryl oxalate
Peripheral arterial disease
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
NICE
Nalbuphine hydrochloride
No Information Returned
01.06.06
Naldemedine
Constipation
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
R
NICE
Important
Opioid-induced constipation. Only after other laxatives have been unsuccessful.
Nalidixic acid
No Information Returned
Nalmefene
No Information Returned
01.06.06
Naloxegol
Constipation
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Opioid-induced constipation. Only after other laxatives have been unsuccessful.
Naloxone hydrochloride
No Information Returned
01.06.06
04.10.03
Naltrexone hydrochloride
Multiple sclerosis
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Un
04.05.01
Naltrexone with bupropion
Weight management in adults
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NFD1
NICE
Naltrexone/bupropion
No Information Returned
Nandrolone decanoate
No Information Returned
Naphazoline hydrochloride
No Information Returned
10.01.01
Naproxen
Pain & inflammation - musculoskeletal
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Preferred
10.01.01
Naproxen
Dysmenorrhoea
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
10.01.01
Naproxen
Pain & inflammation - musculoskeletal
Green (see narrative)
Formulations :
  • Effervescent tablets
  • Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Effervescent tablets and oral suspension are much more expensive and should be reserved for patients in whom ibuprofen suspension is not suitable. Reserve oral suspension for patients with sodium restriction or for children.
10.01.01
Naproxen
Pain & inflammation - musculoskeletal
Non Formulary
Formulations :
  • Gastro-resistant tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Important
More expensive that standard tablets and offer no additional gastro-protection.
Naproxen sodium
No Information Returned
01.03.05
10.01.01
Naproxen with esomeprazole
Pain & inflammation - musculoskeletal
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
04.07.04
Naratriptan hydrochloride
Migraine (acute)
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Preferred
Prescribe generically
Natalizumab
No Information Returned
Natamycin
No Information Returned
Nateglinide
No Information Returned
02.04.00
Nebivolol
Hypertension
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
02.04.00
Nebivolol
Heart failure
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Prescribing in primary care on specialist recommendation.
Nedocromil sodium
No Information Returned
Nefazodone hydrochloride
No Information Returned
04.07.01
Nefopam hydrochloride
Pain
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Important
Reserve for when alternatives are contraindicated or ineffective. At RSFT - initiation by pain team only.
Nelarabine
No Information Returned
Nelfinavir mesilate
No Information Returned
05.01.04
12.02.03
Neomycin sulfate
Antibiotic Prophylaxis for colorectal surgery
Red
Formulations :
  • Solution
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
10.02.01
Neostigmine bromide
Myasthenia gravis
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Neostigmine metilsulfate
No Information Returned
11.08.02
Nepafenac
Postoperative pain and inflammation (eye)
Red
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Netilmicin sulfate
No Information Returned
04.06.00
Netupitant/palonosetron hydrochloride
Nausea and vomiting (chemotherapy induced)
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
05.03.01
Nevirapine
Prevention of HIV vertical transmission
Red
Formulations :
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
NHSE
Important
Restricted use - prevention of vertical transmission in babies born to HIV-positive mothers. Use as recommended in BHIVA guidelines
02.06.02
Nicardipine hydrochloride
Hypertension
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Specialist only
02.06.03
Nicorandil
Angina
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Nicotinamide
No Information Returned
Nicotinates
No Information Returned
Nicotine
No Information Returned
Nicotine bitartrate
No Information Returned
02.12.00
Nicotinic acid
Familial hypercholesterolaemia
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Nicotinic acid derivatives
No Information Returned
Nicotinic acid/laropiprant
No Information Returned
01.07.04
02.06.02
Nifedipine
Angina
Green
Formulations :
  • Modified release tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe by BRAND.
Tensipine MR (Twice daily) and Adipine XL (once daily) are the preferred tablet brands.
01.07.04
02.06.02
Nifedipine
Angina
Green
Formulations :
  • Modified release capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe by BRAND.
Coracten SR (Twice daily) and Coracten XL (once daily) are the preferred capsule brands.
01.07.04
02.06.02
Nifedipine
Hypertension
Green
Formulations :
  • Modified release tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
Prescribe by BRAND
Tensipine MR (Twice daily) and Adipine XL (once daily) are the preferred tablet brands.
01.07.04
02.06.02
Nifedipine
Hypertension
Green
Formulations :
  • Modified release capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
Prescribe by BRAND
Coracten SR (Twice daily) and Coracten XL (once daily) are the preferred capsule brands.
01.07.04
02.06.02
Nifedipine
Hypertension
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
Prescribe by BRAND
01.07.04
02.06.02
Nifedipine
Raynaud's Phenomenon
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Nifurtimox
No Information Returned
Nilotinib
No Information Returned
02.06.02
Nimodipine
Subarachnoid haemorrhage
Red
Formulations :
  • Tablets
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Nintedanib
No Information Returned
Niraparib
No Information Returned
Nirmatrelvir with Ritonavir
No Information Returned
Nisoldipine
No Information Returned
05.01.07
05.03.03
Nitazoxanide
Hepatitis C
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NHSE
Nitisinone
No Information Returned
Nitrazepam
No Information Returned
05.01.13
Nitrofurantoin
Bacterial infection
Green
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
SA
Important
Follow local guidelines on the use of antimicrobials.
Nitrous oxide
No Information Returned
Nivolumab
No Information Returned
01.03.01
Nizatidine
Acid suppression (Adults)
Green (see narrative)
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Preferred
For use where a PPI is not suitable and an H2RA is indicated. For doses of 300mg, please prescribe 2x150mg as this is considerably more cost effective.
Nonoxinol 9
No Information Returned
Noradrenaline acid tartrate
No Information Returned
06.04.01
07.03.02
Norethisterone
Menorrhagia
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Norethisterone enantate
No Information Returned
05.01.12
Norfloxacin
Bacterial infection
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Norgestrel
No Information Returned
Normal immunoglobulin (Gamma globulin)
No Information Returned
04.03.01
04.07.03
Nortriptyline
Pain (Neuropathic)
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Noxytiolin
No Information Returned
05.02.03
07.02.02
Nystatin
Candidiasis
Non Formulary
Formulations :
  • Pessaries
  • Vaginal cream
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
 

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq
BlueTeq form to be completed
NICE
NICE

Traffic Light Status Key

Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Black
Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.
Amber Star
Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)
See Below
Please add a description.
N/A
Please add a description.
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green - Black
Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.
See narrative
See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)
Do not initiate in new patients
These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More